Skip to main content

CYCLACT (Micro Labs Pty Ltd)

Product name
CYCLACT
Date registered
Evaluation commenced
Decision date
Approval time
157 (255 working days
Active ingredients
cyclizine lactate
Registration type
New generic medicine
Indication

CYCLACT is indicated for the prevention of nausea and vomiting in the post-operative period.

Help us improve the Therapeutic Goods Administration site